Psychotherapist'S Guide To Psychopharmacology

Second Edition
EPUB
(432 Seiten)
  Sofort lieferbar | Lieferzeit:3-5 Tage I

Unser bisheriger Preis:ORGPRICE: 26,95 EUR

Jetzt 16,92 EUR*

ISBN-13:
9781439136683
Einband:
EPUB
Seiten:
432
Autor:
Michael J. Gitlin
eBook Typ:
Adobe Digital Editions
eBook Format:
EPUB
Kopierschutz:
Adobe DRM [Hard-DRM]
Sprache:
Englisch
Beschreibung:

The last twenty-five years have witnessed an explosion of knowledge about the influence of brain biochemistry on mood and behavior and about pharmacological approaches to treating mental and emotional disorders. A substantial portion of patients seen in clinical practice are taking some medication or might usefully be advised to do so. But many clinical psychologists, social workers, and counselors need additional information in order to better treat patients already on medication, know when and to whom to refer new patients for psychiatric consultation, and work collaboratively with psychiatrists when appropriate.Michael J. Gitlin's indispensable first edition of The Psychotherapists Guide to Psychopharmacology has now been updated and revised -- this new second edition now reflects major changes that have influenced the clinical arena in the last five years such as the recent release of DSM-IV and the domination of the psychopharmacological field by the selective serotonin reuptake inhibitors, such as fluoxetine (Prozac). The Psychotherapists Guide to Psychopharmacology, Second Edition also now includes coverage of attention deficit/hyperactivity disorder and contains updated sections on the new antipsychotics for schizophrenia and the increased use of anticonvulsant mood stabilizers for bipolar disorder. The book also includes other significant changes that have influenced the field over the last few years, such as brain imaging studies, research in obsessive compulsive disorder and social phobia, and such prominent topics in women's health as pregnancy, PMS, postpartum disorders, and breast feeding.This revision of an already established guide will again be an essential reference for all nonmedical professionals involved in treating mental and emotional disorders.
The last twenty-five years have witnessed an explosion of knowledge about the influence of brain biochemistry on mood and behavior and about pharmacological approaches to treating mental and emotional disorders. A substantial portion of patients seen in clinical practice are taking some medication or might usefully be advised to do so. But many clinical psychologists, social workers, and counselors need additional information in order to better treat patients already on medication, know when and to whom to refer new patients for psychiatric consultation, and work collaboratively with psychiatrists when appropriate.
ContentsList of Illustrations and TablesPrefaceAcknowledgmentsSECTION ONE1. Diagnosis and Treatment: Basic PrinciplesDescriptive Psychiatry and DSM-IVPharmacotherapy and Its Implications for Other TherapiesEvaluating Treatments: The Meaning of the Word EffectiveGoals of PharmacotherapySome General Issues in Psychopharmacological TreatmentFDA Approval and PDR DosesPolypharmacyPractice GuidelinesWho Should Have a Medication Consultation?SECTION TWO2. Biological Basis of PsychopharmacologyNeurotransmission: How Cells CommunicateHow Medications WorkNeurotransmitters That Help Regulate Mood and BehaviorNeuroimaging Techniques in Psychiatric DisordersBiological Hypotheses of the Major Psychiatric DisordersMood DisordersSchizophreniaAnxiety DisordersSECTION THREE3. Mood DisordersDiagnosisMajor DepressionSubtypes of Major Depressive DisorderMelancholic DepressionMajor Depression with Psychotic FeaturesAtypical DepressionSeasonal DepressionPostpartum DepressionBipolar DisorderNatural History, Epidemiology, and GeneticsPresentations of Mild Mood DisordersDysthymiaCyclothymiaRecurrent Brief Depressions and Minor DepressionsMedical Differential Diagnosis and EvaluationMedications Causing DepressionLaboratory EvaluationPsychiatric Differential DiagnosisDepressionMourningDemoralizationAdjustment Disorder with Depressed MoodPremenstrual SyndromeDementia SyndromesManiaPsychopharmacological TreatmentPharmacotherapy of Major Depression (Unipolar Depression)First-Line AgentsSecond-Line AgentsMonoamine Oxidase (MAO) InhibitorsElectroconvulsive TreatmentOther OptionsMood StabilizersStimulantsLight TherapyAntianxiety AgentsStrategies Used in Treatment-Resistant DepressionsContinuation Treatment of Unipolar DepressionMaintenance Treatment of Unipolar DisorderPharmacotherapy of Bipolar DisorderTreatment of Acute Manic EpisodesContinuation Treatment of Manic or Hypomanic EpisodesBipolar Depression -- Acute and Continuation TreatmentMaintenance Treatment of Bipolar Disorder4. Anxiety Disorders and InsomniaDiagnosisNatural History, Epidemiology, and GeneticsMedical Differential DiagnosisMedical and Laboratory EvaluationPsychiatric Differential DiagnosisPsychopharmacological TreatmentAcute Treatment of Panic DisorderContinuation and Maintenance Treatment for Panic DisorderSocial PhobiaObsessive Compulsive DisorderPost-traumatic Stress DisorderGeneralized Anxiety DisorderContinuation and MaintenanceTreatment of Generalized AnxietyInsomniaDiagnosisTreatment5. Schizophrenia and Related DisordersDiagnosisSubtypes of SchizophreniaNatural History, Epidemiology, and GeneticsDisorders Related to SchizophreniaSchizophreniform DisorderSchizoaffective DisorderDelusional DisorderSchizotypal Personality DisorderMedical Differential DiagnosisLaboratory EvaluationPsychiatric Differential DiagnosisPsychopharmacological TreatmentPsychopharmacological Treatment of Acute SchizophreniaAlternative Treatments of Acute SchizophreniaAcute Treatment of Schizoaffective DisorderContinuation Treatment of Acute SchizophreniaMaintenance Treatment of SchizophreniaMaintenance Treatment of Schizoaffective DisorderTreatment of Depression in Schizophrenia6. Disorders of Impulse Control: Eating Disorders, Drug and Alcohol Abuse, and Adult Attention Deficit/Hyperactivity Disorder (ADHD)Eating DisordersAnorexia NervosaBulimia NervosaAdult Attention Deficit/Hyperactivity DisorderPsychopharmacological TreatmentAlcohol and Drug AbuseAlcohol AbuseCocaine AbuseOpiate Abuse (Heroin and Narcotic Analgesics)Other Drugs7. Personality DisordersDiagnosisSubtypesCluster A: Odd or Eccentric Personality DisordersCluster B: Emotional or Chaotic Personality DisordersCluster C: Anxious or Fearful Personality DisordersNatural History, Epidemiology, and GeneticsPsychopharmacological Treatment of Personality DisordersConceptual Models of Pharmacotherapy: What Are We Treating?Psychopharmacological Treatment of Specific Personality DisordersCluster A: Odd or Eccentric Personality Types ClusterB: Emotional or Chaotic Personality Types ClusterC: Anxious or Fearful TypesDepressive Spectrum Personality DisordersManagement Issues8. Treatment of Special Populations: Children/Adolescents, the Elderly, and WomenChild and Adolescent DisordersMood DisordersDiagnosisPharmacotherapyChildhood SchizophreniaDiagnosisPharmacotherapyPervasive Developmental Disorders: Autistic Disorder, Asperger's Syndrome, and Related EntitiesDiagnosisPharmacotherapyAnxiety DisordersDiagnosisPharmacotherapyAttention Deficit/Hyperactivity DisorderDiagnosisPharmacotherapySleep DisordersDiagnosisPharmacotherapyBehavioral ConditionsEnuresisConduct DisorderAggressive, Destructive Behavior in Mentally Retarded ChildrenTourette's DisorderDiagnosisPharmacotherapyGeriatric DisordersPharmacotherapy for Common DisordersMood DisordersPsychotic DisordersAnxiety Disorders and InsomniaMedications Used in Treating DementiasFemale-Specific Issues and DisordersPremenstrual SyndromeMedications During PregnancyAntidepressantsAntianxiety DrugsMood StabilizersAntipsychoticsElectroconvulsive TreatmentPostpartum Period and BreastfeedingMenopauseSECTION FOUR9. AntidepressantsHistoryClassificationCyclic AntidepressantsClinical UsesBiologic EffectsChoosing a Cyclic AntidepressantAntidepressant Classes: Prescribing Techniques and Side EffectsGeneral PrinciplesSelective Serotonin Reuptake Inhibitors (SSRIs)Novel AntidepressantsTricyclic Antidepressants (and Related Compounds)Monoamine Oxidase (MAO) InhibitorsClinical UsesBiologic EffectsChoice of Agents and Techniques for PrescribingFood and Drug InteractionsOther Side Effects10. Lithium and Other Mood StabilizersHistoryLithiumClinical UsesBiologic EffectsTechniques for PrescribingSide EffectsLithium's Effects on Thyroid and KidneysLithium ToxicityLithium DiscontinuationAnticonvulsant Mood StabilizersCarbamazepineClinical UsesBiologic EffectsTechniques for PrescribingSide EffectsValproateClinical UsesBiologic EffectsTechniques for PrescribingSide Effects11. Antianxiety Medications and HypnoticsHistoryBenzodiazepinesClinical UsesBiologic EffectsChoosing a BenzodiazepineTechniques for PrescribingBenzodiazepine WithdrawalOther Side EffectsZolpidem BuspironeNonbarbiturate Sedatives and HypnoticsBarbituratesL-Tryptophan and MelatoninAntihistaminesClonidineBeta-blockersIn the Future12. AntipsychoticsHistoryClinical UsesBiologic EffectsChoosing an AntipsychoticAtypical AntipsychoticsTechniques for PrescribingSide EffectsAcute Side EffectsDystonic ReactionsAkinesiaAkathisiaNeurolepticMalignant SyndromeNon-Neurological Side EffectsTardive DyskinesiaAntiparkinsonian Medications13. Electroconvulsive Therapy (ECT); StimulantsECTClinical UsesMechanisms of ActionTechniques of AdministrationSide EffectsStimulantsClinical UsesMechanisms of ActionTechniques of AdministrationSide EffectsSECTION FIVE14. The Split Treatment Model: Interactions Between Psychotherapy and PharmacotherapyEarly Models, Early ProblemsPsychotherapy/Pharmacotherapy Interactions: Theoretical IssuesTherapeutic Split ModelAdvantages of the Split ModelDisadvantages of the Split ModelPsychodynamics of PsychopharmacologyPatient EducationMedication Compliance: Intra- and Interpersonal FactorsTechnical Aspects of Split TreatmentChoosing a PsychopharmacologistFinding a Psychopharmacologist in Your Community or GroupThe Consultation ProcessThe Initial ConsultationWorking in an Ongoing Split TreatmentAppendix: Psychiatric MedicationsReferencesIndex
The last twenty-five years have witnessed an explosion of knowledge about the influence of brain biochemistry on mood and behavior and about pharmacological approaches to treating mental and emotional disorders. A substantial portion of patients seen in clinical practice are taking some medication or might usefully be advised to do so. But many clinical psychologists, social workers, and counselors need additional information in order to better treat patients already on medication, know when and to whom to refer new patients for psychiatric consultation, and work collaboratively with psychiatrists when appropriate.Michael J. Gitlin's indispensable first edition of The Psychotherapists Guide to Psychopharmacology has now been updated and revised -- this new second edition now reflects major changes that have influenced the clinical arena in the last five years such as the recent release of DSM-IV and the domination of the psychopharmacological field by the selective serotonin reuptake inhibitors, such as fluoxetine (Prozac). The Psychotherapists Guide to Psychopharmacology, Second Edition also now includes coverage of attention deficit/hyperactivity disorder and contains updated sections on the new antipsychotics for schizophrenia and the increased use of anticonvulsant mood stabilizers for bipolar disorder. The book also includes other significant changes that have influenced the field over the last few years, such as brain imaging studies, research in obsessive compulsive disorder and social phobia, and such prominent topics in women's health as pregnancy, PMS, postpartum disorders, and breast feeding.This revision of an already established guide will again be an essential reference for all nonmedical professionals involved in treating mental and emotional disorders.

Kunden Rezensionen

Zu diesem Artikel ist noch keine Rezension vorhanden.
Helfen sie anderen Besuchern und verfassen Sie selbst eine Rezension.